The company said it will continue developing the drug for posttraumatic stress disorder (PTSD). The preliminary topline results revealed that TNX-102 SL, taken once-daily at a 2.8-mg dosage,
Fulcrum will use Horizon's CRISPR screening platform to find targets for regulating gene expression in diseases with no current treatment options. The initial program features two projects with
The National Institute of Allergy and Infectious Diseases (NIAID), part of the US National Institutes of Health, sponsored the two-stage study, which was carried out at the NIAID
In the trials, dubbed Sirocco and Calima, a total of 2,511 patients who were receiving standard-of-care therapy, including inhaled corticosteroids and long-acting beta 2 agonists, were randomized to
An independent adjudication and analysis of major adverse cardiovascular events confirmed an increased risk of stroke. The company said while odanacatib reduces the risk of osteoporotic fractures, the
The US Biomedical Advanced Research and Development Authority (BARDA) has selected the company’s vaccine business unit to develop an inactivated, adjuvanted, whole Zika virus vaccine. Takeda will receive
The fast track status provides for more frequent meetings with the FDA review team and a rolling review of the new drug application. Biogen executive vice president and
The Ministry of Health (MOH) said that 24 new cases have been identified and a new potential cluster has been discovered at Bedok North Avenue 3. A pregnant
In July, the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) adopted a positive opinion recommending approval. The drug is already approved in Europe to
Erelzi is approved for all indications present in the reference product's label including rheumatoid arthritis (RA), plaque psoriasis (PsO), psoriatic arthritis (PsA), ankylosing spondylitis (AS) and polyarticular juvenile
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.